Glaukos Corporation - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
GKOS New York 2830 www.glaukos.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Glaukos Corporation

Can ISRG's 'Quintuple Aim' Strategy Continue to Justify Premium Pricing? - Jun 29th, 2026 11:36 am
Glaukos Announces Completion of Patient Enrollment in Phase 2 Study of GLK-321 for Demodex Blepharitis - Jun 25th, 2026 5:00 am
A Look At Glaukos (GKOS) Valuation After Recent Share Price Swings - Jun 9th, 2026 7:11 am
Here's Why You Should Retain Glaukos Stock in Your Portfolio Now - Jun 5th, 2026 12:11 pm
Medical Device Stocks Are Ready to Bounce. Two Names to Buy Now. - May 13th, 2026 12:52 pm
Glaukos Announces Participation in Upcoming Investor Conferences - May 12th, 2026 5:00 am
Presbyopia Market to Witness Accelerated Growth at a CAGR of 4.9% During the Forecast Period (2026–2036) Supported by Expanding Treatment Landscape | DelveInsight - May 11th, 2026 11:00 am
How The Glaukos (GKOS) Narrative Is Shifting With New Guidance And Product Ramp Expectations - May 3rd, 2026 8:13 pm
Two Medical Stocks Skyrocket After Demolishing Views — And One Is About To Break Out - Apr 30th, 2026 2:06 pm
Glaukos Gains on Q1 Earnings Beat & Improved 2026 Revenue Outlook - Apr 30th, 2026 8:53 am
Glaukos Q1 Earnings Call Highlights - Apr 30th, 2026 2:05 am
Glaukos Corp (GKOS) Q1 2026 Earnings Call Highlights: Record Sales Surge and Raised Guidance - Apr 30th, 2026 1:17 am
Glaukos (GKOS) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates - Apr 29th, 2026 7:00 pm
Glaukos Corporation Q1 2026 Earnings Call Summary - Apr 29th, 2026 6:26 pm
Glaukos (GKOS) Reports Q1 Loss, Tops Revenue Estimates - Apr 29th, 2026 4:40 pm
Glaukos Announces First Quarter 2026 Financial Results - Apr 29th, 2026 2:05 pm
Is ISRG's International Weakness a Temporary Drag or Structural Risk? - Apr 29th, 2026 6:31 am
3 Stocks Estimated To Be Trading Up To 43% Below Intrinsic Value - Apr 28th, 2026 11:38 am
Ligand Pharmaceuticals And 2 Other Stocks That May Be Trading At An Estimated Discount - Apr 28th, 2026 5:38 am
April 2026's Top 3 Stocks That May Be Trading Below Estimated Fair Value - Apr 27th, 2026 11:38 am